Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.”… Read more »
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options… Read more »
This month, Cancer Commons earned the 2020 Platinum Seal of Transparency from GuideStar, a database that helps the public evaluate the performance of all nonprofits in the U.S. The Platinum Seal of Transparency is the highest level of recognition offered… Read more »
A new article published by Lets Win! Pancreatic Cancer highlights our virtual tumor boards, which provide “a highly customized experience, connecting patients with our collaborative network of nurse navigators, PhD scientists, and national experts.” This free service helps people find their best-possible… Read more »
A new article published in J. The Jewish News of Northern California tells the tale of our founder, Marty Tenenbaum, PhD, and how his own experience with metastatic melanoma inspired him to create Cancer Commons: “Not only did I have a disease which… Read more »
In a new piece for Oncology Nurse Advisor, our Nurse Navigator Leslie Jared, RN, MSN, and Executive Director Erika Vial Monteverdi highlight Cancer Commons as the best place for patients to go “when it seems there is nowhere to turn.”… Read more »
In a new guest post on the Amazon Web Services (AWS) Blog, our Executive Director Erika Vial Monteverdi highlights how we apply AWS. Cancer Commons learns from the experiences and outcomes of all patients we serve. This process requires sophisticated computing and… Read more »
“We need to break down the barriers between health institutions to allow patients and their trusted clinicians to access global data about individual patient treatment decisions and outcomes.” … A new article written by lymphoma patient Brad Power outlines why… Read more »
By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led this research,… Read more »
Around the world, physicians are seeking better treatments for COVID-19. What can they learn from cancer research? Today, STAT published an article written by Cancer Commons founder Marty Tenenbaum, PhD, in which he outlines how our strategy to learn from… Read more »